Mediclinic International plc
(Incorporated in England and Wales)
Company Number: 08338604
LSE Share Code: MDC
JSE Share Code: MEI
NSX Share Code: MEP
ISIN: GB00B8HX8Z88
1 March 2016
TOTAL VOTING RIGHTS
In accordance with Disclosure and Transparency Rule 5.6.1R, as at 29 February 2016, the issued share capital and voting rights of Mediclinic International plc were as follows:
Class of shares in issue |
Ordinary shares of 10p each
|
Number of ordinary shares in issue |
737,243,810
|
Number of shares held in Treasury
|
0
|
Total nominal value of issued shares |
GBP 73,724,381
|
Total Voting Rights |
737,243,810
|
The above total voting rights figure (737,243,810) may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interests in, or a change to their interest in Mediclinic International plc under the FCA's Disclosure and Transparency Rules.
For the purpose of the Transparency Directive the Home Member State of the issuer is the United Kingdom.
For and on behalf of Mediclinic International plc
Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom
Website: www.mediclinic.com
JSE sponsor: RAND MERCHANT BANK (A division of FirstRand Bank Limited)
NSX sponsor: Simonis Storm Securities (Pty) Limited
For further information, please contact:
Company Secretary - Capita Company Secretarial Services Limited
Victoria Dalby +44 (0)207 954 9528